|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/15/21 Organovo Holdings, Inc. 10-K 3/31/21 74:7.1M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 652K
2: EX-4.1 Instrument Defining the Rights of Security Holders HTML 44K
3: EX-21.1 Subsidiaries List HTML 22K
4: EX-23.1 Consent of Expert or Counsel HTML 22K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
14: R1 Document and Entity Information HTML 86K
15: R2 Consolidated Balance Sheets HTML 81K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 32K
17: R4 Consolidated Statements of Operations and Other HTML 81K
Comprehensive Loss
18: R5 Consolidated Statements of Stockholders' Equity HTML 66K
19: R6 Consolidated Statements of Cash Flows HTML 108K
20: R7 Description of Business and Summary of Significant HTML 72K
Accounting Policies
21: R8 Fixed Assets HTML 68K
22: R9 Accrued Expenses HTML 41K
23: R10 Collaborative Research, Development, and License HTML 48K
Agreements
24: R11 Stockholders' Equity HTML 193K
25: R12 Leases HTML 31K
26: R13 Commitments and Contingencies HTML 29K
27: R14 Income Taxes HTML 106K
28: R15 Concentrations HTML 25K
29: R16 Related Parties HTML 29K
30: R17 Defined Contribution Plan HTML 25K
31: R18 Recent Accounting Pronouncements HTML 33K
32: R19 Restructuring HTML 52K
33: R20 Subsequent Events HTML 27K
34: R21 Description of Business and Summary of Significant HTML 121K
Accounting Policies (Policies)
35: R22 Recent Accounting Pronouncements (Policies) HTML 26K
36: R23 Fixed Assets (Tables) HTML 72K
37: R24 Accrued Expenses (Tables) HTML 41K
38: R25 Collaborative Research, Development, and License HTML 38K
Agreements (Tables)
39: R26 Stockholders' Equity (Tables) HTML 186K
40: R27 Income Taxes (Tables) HTML 101K
41: R28 Restructuring (Tables) HTML 52K
42: R29 Description of Business and Summary of Significant HTML 131K
Accounting Policies - Additional Information
(Detail)
43: R30 Fixed Assets - Schedule of Fixed Assets (Detail) HTML 34K
44: R31 Fixed Assets - Additional Information (Detail) HTML 24K
45: R32 Fixed Assets - Summary of Assets Held for Sale HTML 32K
(Detail)
46: R33 Accrued Expenses - Summary of Accrued Expenses HTML 32K
(Detail)
47: R34 Collaborative Research, Development, and License HTML 98K
Agreements - Additional Information (Detail)
48: R35 Collaborative Research, Development, and License HTML 30K
Agreements - Schedule of Capitalized License Fees
(Detail)
49: R36 Stockholders' Equity - Schedule of Stock-based HTML 30K
Compensation Expense (Detail)
50: R37 Stockholders' Equity - Stock-based Compensation HTML 38K
Expense and Valuation Information - Additional
Information (Detail)
51: R38 Stockholders' Equity - Fair Value of Employee HTML 34K
Stock Options (Detail)
52: R39 Stockholders' Equity - Fair Value of Employee HTML 40K
Stock Purchase Plan (Detail)
53: R40 Stockholders' Equity - Fair Value of Employee HTML 26K
Stock Purchase Plan (Parenthetical) (Detail)
54: R41 Stockholders' Equity - Preferred Stock - HTML 26K
Additional Information (Detail)
55: R42 Stockholders' Equity - Common Stock - Additional HTML 116K
Information (Detail)
56: R43 Stockholders' Equity - Restricted Stock Units and HTML 26K
Performance-Based Restricted Stock Units -
Additional Information (Detail)
57: R44 Stockholders' Equity - Summary of Company's RSUs HTML 50K
Activity and Performance Based Restricted Stock
Unit Activity (Detail)
58: R45 Stockholders' Equity - Restricted Stock Awards, HTML 95K
Restricted Stock Units and Performance-Based
Restricted Stock Units - Additional Information
(Detail)
59: R46 Stockholders' Equity - Stock Options and Employee HTML 85K
Stock Purchase Plan - Additional Information
(Detail)
60: R47 Stockholders' Equity - Summary of Stock Option HTML 54K
Activity (Detail)
61: R48 Stockholders' Equity - Common Stock Reserved for HTML 40K
Future Issuance (Detail)
62: R49 Leases - Additional Information (Details) HTML 72K
63: R50 Income Taxes - Summary of Reconciliation of HTML 70K
Statutory Federal Rate and Effective Rate for
Operations (Detail)
64: R51 Income Taxes - Summary of Net Deferred Tax Assets HTML 42K
(Detail)
65: R52 Income Taxes - Additional Information (Detail) HTML 51K
66: R53 Related Parties - Additional Information (Detail) HTML 45K
67: R54 Defined Contribution Plan - Additional Information HTML 26K
(Details)
68: R55 Restructuring - Additional Information (Details) HTML 42K
69: R56 Restructuring - Summary of Restructuring Charges HTML 30K
Recorded in Selling, General and Administrative
Expenses (Details)
70: R57 Restructuring - Summary of Activity and Balances HTML 32K
of Restructuring Reserve (Details)
71: R58 Subsequent Events - Additional Information HTML 32K
(Detail)
73: XML IDEA XML File -- Filing Summary XML 131K
72: EXCEL IDEA Workbook of Financial Reports XLSX 101K
8: EX-101.INS XBRL Instance -- onvo-20210331 XML 1.62M
10: EX-101.CAL XBRL Calculations -- onvo-20210331_cal XML 148K
11: EX-101.DEF XBRL Definitions -- onvo-20210331_def XML 595K
12: EX-101.LAB XBRL Labels -- onvo-20210331_lab XML 1.27M
13: EX-101.PRE XBRL Presentations -- onvo-20210331_pre XML 964K
9: EX-101.SCH XBRL Schema -- onvo-20210331 XSD 184K
74: ZIP XBRL Zipped Folder -- 0001564590-21-032980-xbrl Zip 156K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Organovo Holdings, Inc. (the “Company”) for the year ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), Keith Murphy, Executive Chairman of the Company, and Jonathan Lieber, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: June 15, 2021
|
/s/ Keith Murphy |
|
Executive Chairman |
|
/s/ Jonathan Lieber |
|
Chief Financial Officer (Principal Financial Officer) |
A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/15/21 | |||
| For Period end: | 3/31/21 | 10-K/A | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/21 Organovo Holdings, Inc. S-8 11/09/21 3:88K Donnelley … Solutions/FA 7/29/21 Organovo Holdings, Inc. 10-K/A 3/31/21 12:1.3M ActiveDisclosure/FA |